Palmar fascial fibromatosis (Dupuytren)
ICD-10 Code: M72.0 · Body Part: Wrist/Hand
QME Evaluation Process
Hand examination for nodules and contracture, finger ROM testing. UE impairment based on digit flexion contracture severity.
Typical Impairment Rating
3-12% UE (2-7% WPI) based on contracture severity
AMA Guides Edition
5th Edition
Common Treatments
Related Conditions
Body Part Guide
Wrist/Hand Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Palmar fascial fibromatosis (Dupuytren)
Find a QME Specialist
Browse QME-certified physicians who evaluate palmar fascial fibromatosis (dupuytren) and related wrist/hand conditions in California.
Browse Physical Medicine & Rehabilitation Physicians →Frequently Asked Questions
What is Palmar fascial fibromatosis (Dupuytren) (M72.0)?
Palmar fascial fibromatosis (Dupuytren) is an ICD-10 diagnosis code (M72.0) classified under Musculoskeletal conditions. It affects the Wrist/Hand and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is M72.0 rated for impairment?
The typical whole person impairment (WPI) range for Palmar fascial fibromatosis (Dupuytren) is 3-12% UE (2-7% WPI) based on contracture severity. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for M72.0?
Hand examination for nodules and contracture, finger ROM testing. UE impairment based on digit flexion contracture severity.
What treatments are common for Palmar fascial fibromatosis (Dupuytren)?
Common treatments for Palmar fascial fibromatosis (Dupuytren) include Collagenase injection, Needle aponeurotomy, Fasciectomy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.